LINC00511 and melanoma: In a study in melanoma, it was shown that 2′-FANA modified oligonucleotides either antisense to lncRNA SLNCR1 androgen receptor (AR)-binding sequence or mimicking the AR binding site of SLNCR1, inhibits the interaction between the two, suppressing melanoma invasion [119].